Analysis of fucosylated glycoconjugates in rat prostate by lectin blotting with Aleuria aurantia lectin revealed that the tissue contained characteristic low-molecular weight species (prostatic fucosylated glycoconjugates, PFGs). PFGs were detected almost exclusively in the ventral lobe of the prostate among rat tissues examined, and showed an apparent positive androgen dependency, that is, the content of PFGs decreased after castration and then slowly recovered upon androgen replacement. PFGs were resistant to solubilization with Triton X-100, but could be extracted with chloroform-methanol. Treatment of the crude PFG preparation with endoglycoceramidase resulted in the complete disappearance of PFGs. PFGs were also susceptible to 1,3/4-L-fucosidase but not to peptide-N-glycosidase F. Prostate-specific expression of PFGs was confirmed by thin layer chromatography and subsequent blot analysis. These results suggest that PFGs are fucosylated glycosphingolipid species specifically expressed in the rat ventral prostate, and that PFG expression is associated with some androgen-regulated processes in the tissue.
The prostate is a unique organ in that it undergoes rapid apoptotic cell death upon withdrawal of androgen on castration, and the atrophied tissue is capable of regrowth after androgen replacement in adult animals. These processes are controlled by a network of genes that are regulated directly or indirectly by ligandactivated androgen receptor. 1) In a previous study, we carried out subtractive hybridization to obtain a cDNA library enriched in transcripts transiently upregulated after androgen stimulation in the castrated rat ventral prostate, aiming to find novel factors that participate in androgen-stimulated prostate cell growth.
2) On analyzing about 300 clones, we identified several novel transcripts that showed expected changes during androgen manipulation. In addition, a few clones that exhibited simple positive androgen dependency (i.e., the transcripts decreased after castration and returned to normal level or higher upon androgen stimulation) were obtained. One of the latter clones, AIEG856, corresponded to the 3 0 non-coding region of rat fucosyltransferase 4 mRNA (unpublished results).
Fucosylation catalyzed by fucosyltransferases is one of the most common modifications of oligosaccharides on glycoproteins and glycolipids. In mammals, fucosylated glycans linked to proteins (N-glycans and O-glycans) are involved in a variety of processes including cell adhesion, 3, 4) fertilization, 5) and immune responses. [6] [7] [8] [9] Regulation of Notch signaling by Ofucosylation, a special type of fucosylation, has been well documented. 10) Changes in fucosylation are also related to a number of pathological conditions including chronic diseases 11) and cancer. 12, 13) Modification of glycolipid glycans by fucosylation is implicated in development and cancer: the expression of fucosyl GM1 is developmentally regulated in the nervous system 14) and aberrant fucosylation of glycolipids in various cancer cells has been reported. [15] [16] [17] A recent report by Nimrichter et al. indicated that fucosylated glycosphingolipids function as human neutrophil receptors for E-selectin. 18) In the present study, we analyzed fucosylated glycoconjugates in the prostate in comparison with other rat tissues by lectin blotting with Aleuria aurantia lectin (AAL). Although we initially focused on fucosylated glycoproteins, lectin blotting revealed the presence of low-molecular weight species (prostatic fucosylated glycoconjugates, PFGs) that could be extracted with chloroform-methanol in the ventral prostate. Treatment of PFGs with glycosidases indicated that PFGs are glycosphingolipid species with 1,3/4-linked fucose residue(s). This is the first report that certain fucosylated glycosphingolipids are specifically expressed in the ventral prostate of rat in an androgen-dependent manner.
Materials and Methods
Materials. Biotinylated AAL and biotinylated concanavalin A (ConA) were purchased from Seikagaku Kogyo (Tokyo, Japan). Endoglycoceramidase II (EGCase II), peptide-N-glycosidase F (PNGase F), and 1,3/4-L-fucosidase were purchased from Takara Bio (Shiga, Japan). Gangliosides (Gal1-3GalNAc1-4[NeuAc2-3]Gal1-4Glc1-1 0 ceramide, GM1a and NeuAc2-3Gal1-3GalNAc1-4[NeuAc2-3]Gal1-4Glc1-1 0 ceramide, GD1a) were purchased from Calbiochem (San Diego, CA, USA).
y To whom correspondence should be addressed. Fax: +81-87-891-2260; E-mail: nnishi@med.kagawa-u.ac.jp Abbreviations: AAL, Aleuria aurantia lectin; ConA, concanavalin A; EGCase, endoglycoceramidase; GD1a, NeuAc2-3Gal1-3GalNAc1-4(NeuAc2-3)Gal1-4Glc1-1 0 ceramide; GM1a, Gal1-3GalNAc1-4(NeuAc2-3)Gal1-4Glc1-1 0 ceramide; PFG, prostatic fucosylated glycoconjugate; PNGase F, peptide-N-glycosidase F Biosci. Biotechnol. Biochem., 74 (6), [1261] [1262] [1263] [1264] [1265] [1266] 2010 Animals and animal experiments. The Kagawa University Experimental Animal Research Committee approved all the procedures used in this study. Mature male Sprague-Dawley rats (10 weeks of age) (CLEA Japan, Tokyo, Japan) were castrated by scrotal incision under ether anesthesia. The castrated rats were maintained under standard laboratory conditions for 7 d. Treatment of 7-d castrated rats with exogenous androgen comprised daily subcutaneous injections of testosterone propionate (2 mg/rat) for up to 7 d. At various times following castration and androgen treatment, groups of rats were killed by cervical dislocation. The ventral prostate was removed and frozen in liquid nitrogen for later analysis.
Lectin blot analysis. Lectin blot analyses were carried out as described by Matsumura et al. 19) with modifications. Samples were electrophoretically separated in SDS/12.6% polyacrylamide gels and then transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA). The membranes were incubated with 2% bovine serum albumin in Tris-buffered saline (10 mM Tris-HCl, pH 7.5, 0.15 M NaCl, TBS) for 1 h, and then overnight with 0.5 mg/ml of biotinylated AAL in TBS-T (TBS containing 0.05% Tween 20) . When biotinylated ConA (0.5 mg/ml) was used as a lectin probe, the membranes were blocked with Carbo-Free Blocking Solution (Vector Laboratories, Burlingame, CA, USA). After washing with TBS-T, the membranes were incubated with streptavidine-biotinylated horseradish peroxidase complex (GE Healthcare, Piscataway, NJ, USA) for 1 h, and then washed with TBS-T. Chemiluminescent detection was carried out using ECL reagent (GE Healthcare).
Preparation of subcellular fractions. Rat tissues were minced and then homogenized in 9 volumes (v/w) of 10 mM Tris-HCl (pH 7.5) containing 0.25 M sucrose, 1 mM CaCl 2 and 1 mM phenylmethysulfonyl fluoride. Each homogenate was centrifuged at 100;000 Â g for 1 h. The resulting supernatant was used as the tissue extract. The precipitate, suspended in the original volume of the buffer, was used as the insoluble fraction. For extraction of lipids (see below), the precipitate was centrifugally washed twice with phosphate-buffered saline (PBS) to remove sucrose.
Lipid extraction. The insoluble fraction of each rat tissue was homogenized in 10 volumes per original tissue weight of chloroform:methanol (2:1, v/v), followed by centrifugation. The pellet was extracted again with the same volume of chloroform:methanol (1:2, v/v). The extracts were combined, evaporated to dryness, and then dissolved in chloroform:methanol (2:1). The crude lipid extract was partitioned by the method of Folch et al. 20) The upper phase of the Folch partition that contained PFGs (see ''Results and Discussion'') was designated as the crude PFG preparation.
Thin-layer chromatography (TLC) and TLC blotting. Precoated silica gel 60 TLC plates with an aluminum support (Merck, Darmstadt, Germany) were used. The solvent system used was chloroform:methanol:0.2% CaCl 2 in water (50:50:11, v/v). Glycolipids were detected with orcinol-H 2 SO 4 reagent. TLC blotting (Far-Eastern blot) was carried out as described previously. 21) Briefly, a developed TLC plate was air dried and then immersed for 20 s in a solvent comprising 2-propanol:methanol:0.2% CaCl 2 in water (40:7:20, v/v). The plate was placed silica gel-side up on a glass plate, after which a PVDF membrane and then a glass microfiber sheet were placed on top. The resulting sandwich was pressed for 30 s with a household iron heated to 180 C. Fucosylated glycoconjugates transferred to the membrane were detected with biotinylated AAL as described above.
Enzyme digestion. Samples were dissolved in 35 ml of 20mM sodium acetate buffer (pH 5.0) containing 0.4% Triton X-100. After the addition of 5 ml of EGCase II (2 mU/ml), the mixture was incubated at 37
C for 4 h. The reaction was stopped by heating at 98 C for 3 min. For treatment with fucosidase, samples were dissolved in 25 ml of 100 mM potassium phosphate buffer (pH 6.0) containing 2 M ammonium sulfate. After the addition of 25 ml of 1,3/4-L-fucosidase (1 mU/ml), the mixture was incubated at 37 C for 16 h. The reaction was stopped by heating at 98 C for 3 min. Digestion with PNGase F was carried out according to the manufacturer's instructions under denaturing conditions.
Other methods. Prostatein (prostate -protein), a major secretory protein of rat ventral prostate, was purified by the method described by Chen et al. 22) Protein concentrations were determined using BCA protein assay reagent (Pierce Biotechnology, Rockford, IL, USA) with bovine serum albumin as a standard.
Results and Discussion
Analysis of fucosylated glycoconjugates in rat tissues by lectin blot Lectin blotting with AAL was carried out to examine fucosylation in rat prostate. AAL is a fucose-specific lectin exhibiting high affinity for 1,6-fucosylated oligosaccharides.
19) It also exhibits a broad specificity for 1,2-, 1,3-, and 1,4-linked fucose residues.
23) The rat ventral prostate tissue extract contained a major fucosylated substance with a molecular weight of about 14,000 (Fig. 1C, lane 9) . ConA also recognized this substance (Fig. 1E, lane 9) . The electrophoretic mobility of the band coincided with that of the C3 component of prostatein (Fig. 1A, C , and E, lane 11), a major secretory protein of rat ventral prostate. Prostatein, which accounts for about 30% of the soluble protein in the tissue, is composed of three different peptides, C1, C2, and C3. Among them only the C3 component is glycosylated. These components form covalent C1:C3 (subunit A) and C2:C3 (subunit B) heterodimers, whose non-covalent association yields tetrameric (C1:C3/ C3:C2) mature prostatein. 22) Thus the C3 component migrates as subunit A and subunit B (two closely located bands corresponding to apparent molecular weights in the range of 20,000-22,000) on SDS-PAGE under nonreducing conditions (Fig. 2A) . In addition to the ventral prostate, two typical exocrine glands, the submaxillary gland and dorsolateral prostate, contained relatively large amounts of fucosylated substances (Fig. 1C, lanes  8 and 10) . The mobilities of the two major bands detected for the dorsolateral prostate coincided with those of dorsal protein I (molecular weight, 62,000) and II (molecular weight, >100;000), secretory proteins predominantly expressed in the tissue, 24) suggesting that all the major fucosylated substances detected in the tissue extracts are secretory components.
The insoluble fraction of rat tissues contained high molecular weight bands recognized by AAL, probably representing fucosylated membrane glycoproteins (Fig. 1D) . In addition to the high molecular weight bands, four distinct bands (bands 1 to 4, numbered from bottom to top) corresponding to molecular weights of less than 20,000 were detectable in the ventral prostate (Fig. 1D, lane 9) . The mobility of band 3 on SDS-PAGE under reducing and non-reducing conditions indicated that the band 3 material was the C3 component (Fig. 2B) . The intensity of band 4 varied markedly from one preparation to another, and thus was not further characterized in the present study. Unlike bands 3 and 4, bands 1 and 2 were not detected on lectin blotting with ConA (Fig. 1F, lane 9) . In addition, neither band showed a mobility shift between reducing and non-reducing conditions (Fig. 2B) . Although it is possible that bands 1 and 2 contained multiple molecular species, the fucosylated glycoconjugates corresponding to these bands were tentatively designated as PFG-1 and PFG-2.
Effect of androgen manipulation on fucosylated glycoconjugates in the ventral prostate
Androgen regulation of fucosylated glycoconjugates in the ventral prostate was studied by means of castration and androgen replacement in young adult rats. The C3 component of prostatein (14-kDa band) in a tissue extract detected with AAL decreased upon castration, and then slowly recovered upon androgen replacement (Fig. 3A) . The change in the content of the C3 component upon castration was more prominent in the insoluble fraction than in the tissue extract (Fig. 3B) . Because the tissue extract contained both the cytosolic fraction and the secretory fluid in the glandular lumen, the limited response of the C3 component in the tissue extract to androgen ablation might reflect the longer half-life of secreted prostatein as compared with that of the intracellular form in the castrated animals. Western blot analysis with anti-prostatein antibodies confirmed the results obtained on lectin blotting with AAL (data not shown). PFG-1 and -2 underwent changes similar to that of the C3 component in the insoluble fraction (Fig. 3B) . It is noteworthy that PFG-2 decreased to an undetectable level 7 d after castration. In the case of PFGs, however, we cannot rule out the possibility that lectin blot analysis detected the changes not only in the whole molecule but also those limited to the oligosaccharide moiety. 
Characterization of PFGs
To determine the molecular nature of PFGs, we tried to solubilize them from the insoluble fraction of the ventral prostate with Triton X-100. Although the band 3 material was almost completely solubilized with the detergent, PFGs were distributed nearly equally in the soluble and the residual fractions (Fig. 4A) . On the other hand, the total lipid fraction (crude lipid extract) prepared by chloroform/methanol extraction contained most of PFG-1 but not PFG-2 or the C3 component (Fig. 4B) . PFG-2 was hardly recovered in the extract or the residue. Currently, the reason for the low recovery of PFG-2 on chloroform/methanol extraction is unknown. With Folch's partitioning procedure, PFG-1 in the crude lipid extract was recovered in the upper phase, as in the case of highly polar lipids such as gangliosides (Fig. 4B ). Since these results suggest that PFG-1 is a fucosylated glycolipid (or a mixture of them), we examined the susceptibility of PFG-1 to glycosidases including EGCase. Treatment of a crude PFG-1 preparation (upper phase on Folch partitioning) with EGCase, which hydrolyzes the glycosidic bond between the oligosaccharide and ceramide of glycosphingolipids, resulted in the complete disappearance of PFG-1 detected with AAL (Fig. 5A) . The C3 component of prostatein was not affected by the enzyme. In contrast, the C3 component but not PFG-1 was susceptible to PNGase F, which cleaves N-glycans between the asparagine residue and the oligosaccharide chain. The fucose residues attached to the oligosaccharide moiety of both PFG-1 and the C3 component were hydrolyzed by 1,3/4-L-fucosidase (Fig. 5B) . The polar, lipid-like nature and the susceptibility to EGCase of PFG-1 consistently indicate that PFG-1 and possibly PFG-2 are fucosylated glycosphingolipid species. Fucosidase treatment suggested that the oligosaccharide chain of PFG-1 (and the C3 component) is modified with 1,3/4-linked fucose residue(s). There is not discrepancy between this result and the sugar-binding specificity of AAL, because AAL has been found to exhibit significant affinity for 1,3-linked fucose residues on frontal affinity chromatography. 25) Nevertheless, we cannot exclude the possibility that PFG-1 and the C3 component have fucose residues in other linkages until our results are confirmed by direct analysis of their oligosaccharide structures.
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Fig. 2. Effects of Reducing Conditions on the Electrophoretic Mobility of Prostatein and PFGs.
A, Purified prostatein (2 mg protein) was separated in SDS/12.6% polyacrylamide gels under reducing (þ2ME) and non-reducing (À2ME) conditions. The gels were stained with Coomassie Brilliant Blue R-250. B, The tissue extract (lane 1, 0.5 mg protein) and insoluble fraction (lane 2, 0.5 mg protein) of the ventral prostate and purified prostatein (lane 3, 0.1 mg protein) were electrophoretically separated under reducing (þ2ME) and non-reducing (À2ME) conditions as above, and then subjected to lectin blotting with AAL. M, molecular weight marker proteins. Analysis of fucosylated glycoconjugates by TLC We found and characterized PFGs by means of SDSpolyacrylamide gel electrophoresis and subsequent lectin blot analysis, which is not a standard analytical method of glycolipids. To confirm the results described in the previous sections, especially the tissue-specific expression of PFGs, a crude lipid extract of rat tissues was subjected to TLC, a commonly used method for lipid analysis. The lipids (glycolipids), separated on TLC plates, were visualized with orcinol reagent or transferred to PVDF membranes (Far-Eastern blot). Fucosylated glycolipids blotted on the membranes were detected with AAL. Glycolipids were most abundant in the brain among the rat tissues examined, while they were only marginally detected in the ventral and dorsolateral prostate (Fig. 6A) . Far-Eastern blotting with AAL revealed the presence of at least two major and one minor fucosylated glycolipid species in the ventral prostate (Fig. 6B) . Their mobilities on TLC were lower than that of GD1a, a disialoganglioside. The presence of fucosylated glycolipids in the lung and brain was unambiguously detected when larger sample amounts were loaded (data not shown). These results are consistent with the tissue-specific expression of PFGs detected on lectin blot analysis, and suggest that PFG-1 is a mixture of at least three fucosylated glycosphingolipid species.
A B
In conclusion, we found that certain fucosylated glycosphingolipids exhibiting relatively high polarity A B are specifically expressed in rat ventral prostate. Furthermore, the expression of the glycosphingolipids was positively regulated by androgen in the tissue. Glycosphingolipids are ubiquitous membrane constituents with characteristic structural and signaling functions. Recent findings suggest that ganglioside GD3, a sialylated glycosphingolipid, plays a key role in apoptosis of neuronal cells, lymphocytes, and tumor cells. [26] [27] [28] Although the precise mechanism of action is not known, GD3 is thought to be translocated from the plasma membrane to the mitochondria upon apoptotic stimuli. 29, 30) After translocation to the mitochondria, GD3 induces the production of reactive oxygen species and the release of mitochondrial proapoptotic proteins, such as cytochrome c, Smac/Diablo, and apoptosis-inducing factor. This indicates the possibility that PFGs are also involved in apoptotic cell death in the prostate. It is of special interest in this context to study the changes in the distribution of PFGs in the early phase of castrationinduced involution of the prostate (1-3 d after castration). We anticipate that the findings in this study might lead to the identification of a novel prostate-specific and androgen-regulated process.
